Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Lancet (London, England)"
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
PubPharm (12)
1
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS) : interim analysis of a phase 3, open-label, randomised controlled trial
enthalten in:
Lancet (London, England)
| 2023
von
Platzbecker, U.
|
Della Porta, M.
|
Santini, V.
| +24
CommentIn: Lancet. 2023 Jul 29;402(10399):348-350. - PMID 37321236
Wird geladen...
2
Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland : a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial
enthalten in:
Lancet (London, England)
| 2023
von
Mohebbi, N.
|
Ritter, A.
|
Wiegand, A.
| +8
CommentIn: Lancet. 2023 Feb 18;401(10376):526-527. - PMID 36708731
Wird geladen...
3
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716) : a randomised, double-blind, phase 3 trial
enthalten in:
Lancet (London, England)
| 2022
von
Luke, J.
|
Rutkowski, P.
|
Queirolo, P.
| +26
CommentIn: Nat Rev Clin Oncol. 2022 Jun;19(6):359. - PMID 35440772
Wird geladen...
4
Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D) : the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India
enthalten in:
Lancet (London, England)
| 2022
von
Khobragade, A.
|
Bhate, S.
|
Ramaiah, V.
| +13
CommentIn: Lancet. 2022 Apr 2;399(10332):1281-1282. - PMID 35366995
Wird geladen...
5
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC) : a double-blind, placebo-controlled, phase 3, randomised trial
enthalten in:
Lancet (London, England)
| 2022
von
ITAC (INSIGHT 013) Study Group
|
Polizzotto, M.
|
Nordwall, J.
| +86
Wird geladen...
6
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019 : a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial
enthalten in:
Lancet (London, England)
| 2022
von
Bravo, L.
|
Smolenov, I.
|
Han, H.
| +44
CommentIn: Lancet. 2022 Jan 29;399(10323):415-417. - PMID 35065704
Wird geladen...
7
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older : an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial
enthalten in:
Lancet (London, England)
| 2022
von
Halperin, S.
|
Ye, L.
|
MacKinnon-Cameron, D.
| +46
CommentIn: Lancet. 2022 Jan 15;399(10321):212-213. - PMID 34953524
Wird geladen...
8
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) : interim results of a randomised, double-blind, controlled, phase 3 trial
enthalten in:
Lancet (London, England)
| 2021
von
Ella, R.
|
Reddy, S.
|
Blackwelder, W.
| +106
CommentIn: Lancet. 2021 Dec 11;398(10317):2134-2135. - PMID 34774194
Wird geladen...
9
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac) : interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
enthalten in:
Lancet (London, England)
| 2021
von
Tanriover, M.
|
Doğanay, H.
|
Akova, M.
| +74
CommentIn: Lancet. 2020 Dec 12;396(10266):1882-1883. - PMID 33308466
Wird geladen...
10
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial
enthalten in:
Lancet (London, England)
| 2021
von
RECOVERY Collaborative Group
|
Abani, O.
|
Abbas, A.
| +98
CommentIn: Lancet. 2021 May 1;397(10285):1599-1601. - PMID 33933194
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Lancet (London, England)
Medienart
12
Aufsätze
12
E-Artikel
12
E-Ressourcen
Zeitschriftentitel
Lancet (London, England)
Thema
12
Clinical Trial, Phase III
12
Journal Article
12
Randomized Controlled Trial
8
COVID-19 Vaccines
8
Research Support, Non-U.S. Gov't
6
Multicenter Study
4
Antibodies, Neutralizing
3
Antibodies, Viral
3
Clinical Trial, Phase II
3
Vaccines, Inactivated
2
Adjuvants, Immunologic
2
Antibodies, Monoclonal, Humanized
2
SARS-CoV-2 inactivated vaccines
2
Spike Glycoprotein, Coronavirus
1
1018 oligonucleotide
1
25DT549L0G
1
34S289N54E
1
3QKI37EEHE
1
415SHH325A
1
5AHC3V2UQS
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2023
5
2022
5
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
12
Englisch
Haven't found what you're looking for?
Wird geladen...